Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Læge Simon Lawaetz Schultz ApS
APS
Active
CVR 44070618
Ulspilsager 49
General medical practice activities · NACE 8621
Est. 2023
1 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK -79K
+2% vs 2023
EBITDA margin
1142.4%
-85% vs 2023
Equity ratio
34.6%
Financial strength
Net profit 2024
DKK 663K
+329% vs 2023
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
0M
2023
-1M
-100%
2024
Key figures
Annual report 2024
Revenue
DKK -79K
+2%
EBITDA
DKK -899K
-85%
Net profit
DKK 663K
+329%
Total assets
DKK 2,5M
+17%
Equity
DKK 858K
+341%
Employees
1
—
Company information
Legal name
Læge Simon Lawaetz Schultz ApS
CVR number
44070618
Legal form
Anpartsselskab
NACE code
8621 · General medical practice activities
Founded
23. maj 2023
Share capital
DKK 40.000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den administrerende direktør alene.
Company purpose
Selskabets formål er at drive speciallægevirksomhed i almen medicin og virksomhed, der er naturligt forbundet hermed.
Contact
Address
Ulspilsager 49
Phone
+4561711558
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in General medical practice activities
Companies in Dragør
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2023
-1M
2024
Income statement
DKK thousands
Item
2023
2024
Revenue
-77
-79
Staff expenses
-408
-820
EBITDA
-486
-899
Depreciation & amort.
-52
-103
EBIT
-537
-1.002
Net financials
736
1.852
Profit before tax
198
850
Tax
44
187
Net profit
155
663
Balance sheet
DKK thousands
Item
2023
2024
Total assets
2.115
2.475
Equity
195
858
Long-term debt
0
0
Short-term debt
1.877
1.525
Total debt
1.877
1.525
Financial ratios
5-year trend
EBITDA margin
-89915600.0%
This company
15.8%
Market median
-569086176% vs market
2023
2024
Equity ratio
34.6%
This company
38.2%
Market median
+9% vs market
2023
2024
Return on equity
77.3%
This company
18.4%
Market median
+320% vs market
2023
2024
Net profit margin
66314200.0%
This company
8.1%
Market median
+818693727% vs market
2023
2024
Asset turnover
-0.03×
This company
1.12×
Market median
-103% vs market
2023
2024
Debt / equity
1.89×
This company
0.62×
Market median
-205% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-05-23 – 2023-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Simon Lawaetz Schultz
Individual
100.0%
100.0%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Læge Simon Lawaetz Schultz ApS also hold positions in
0
other companies.
Person
Role here
Other companies